Nexsen Limited (ASX:NXN)
Australia · Delayed Price · Currency is AUD 0.2350
+0.0250 (11.90%)
At close: Aug 21, 2026
Nexsen Market Cap
Nexsen has a market cap or net worth of 47.05 million as of August 21, 2026.
Market Cap
47.05M
Enterprise Value
40.17M
Revenue
931.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
ChartMarket Cap Chart
Since October 14, 2025, Nexsen's market cap has decreased from 56.05M to 47.05M, a decrease of -16.07%. That is a compound annual growth rate of -18.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 47.05M | 46.88% |
| Dec 31, 2025 | 32.03M | -42.86% |
| Oct 14, 2025 | 56.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 77.36M |
| Avecho Biotechnology | 77.27M |
| Immutep | 75.16M |
| Entropy Neurodynamics | 61.19M |
| Botanix Pharmaceuticals | 54.69M |
| Radiopharm Theranostics | 52.05M |
| Neurizon Therapeutics | 44.96M |
| Imugene | 40.16M |